Journal of Neuro-Oncology and Neuroscience broadcasts latest experimental, empirical, theoretical, clinical observations and interpretations in rare diseases originating from all across the world.The journal promotes communication and sharing of innovations and insights among academicians, researchers, clinicians, physicians and other health care and medical professionals who deal with prevention, diagnosis and treatment of rare diseases. The journal focuses on systematic and scholarly studies aimed at addressing the emerging challenges in rare diseases. The journal emphasizes on novel research on Neuro-Oncology, Pons Varolii,Focal neurologic signs, Astrocytomas, Brain tumor, Glioma, Glioblastoma multiforme, Ependymoma, Epileptic seizure, Neurofibromatosis, Central nervous system, Neural oscillation etc.
The journal has archived resource of several issues from 2016 which tract the significant steps during the evolution of rare diseases studies. All through Jan 2017- Nov 2019 there were 46,242 page views. The total number of returning visitors were 13,596.
The journal’s author base is composed of eminent academicians, scientists and medical professional from diverse geographical regions of the world. Similarly, the reader base also has heterogeneous composition as revealed by Google analytics. On an overall basis, the journal has been successful in collation of quality research outcomes in rare diseases and their wider propagation.
A statistical representation of global users for Journal of Neuro-Oncology and Neuroscience (Source: Google Analytics)
iMedPub was established in the year 2005 and since then has been actively publishing peer-reviewed articles in biomedical and clinical science; material science; mathematics and engineering topics. iMedPub follows standard editorial and production policies with Internationally acclaimed publication practices.
Due to wide variation in the journal portfolio, the publisher site is accessed by various communities of diverse scientific disciplines from reputed research organizations, academic institution and Government bodies. More than 2,822,814 users have accessed the publisher website with more than 7,758,847 page views. These stats reveal that the journal is also immensely popular among scientific societies and organizations. Consequently, the editorial board profiles, authors and their affiliations are also gaining higher visibility.
The number of web sessions, the publisher received was 3,595,693 at the rate of 2.16 new sessions. This implied that new users and visitors are flocking to the publisher bases. A number of users are also revisiting the publisher pages indicating their continued interest in the journal. The fast and efficient publishing standard set by iMedPub was found to be very impressive by the reader base and is being well appreciated; as evident from the web metrics. The metric displayed belong only to our journals and if the associated links are also taken into consideration the number would be significantly much higher.